CompletedNot Applicable

Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy

France41 participantsStarted 2020-11-03

Plain-language summary

Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outcome at 5 years of these two types of management in order to define whether one is superior to the other on this criterion of voice quality after treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with glottic squamous cell carcinoma T1N0M0 who may benefit from treatment with exclusive radiotherapy or exclusive surgery. * patients treated for these cancers at Lille University Hospital and the Oscar Lambret Centre between 2015 and 2017. * Tis, T1a and T1b glottic squamous cell carcinomas according to the TNM 7th edition classification in long-term survivors. Exclusion Criteria: \-

What they're measuring

Voice Handicap Index

Timeframe: At 5 years

Trial details

NCT IDNCT04447456

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-19

View on ClinicalTrials.gov More Glottic Carcinoma trials